---
title: "IRWD.US (IRWD.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/IRWD.US/news.md"
symbol: "IRWD.US"
name: "IRWD.US"
parent: "https://longbridge.com/en/quote/IRWD.US.md"
datetime: "2026-05-20T19:35:00.124Z"
locales:
  - [en](https://longbridge.com/en/quote/IRWD.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/IRWD.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/IRWD.US/news.md)
---

# IRWD.US (IRWD.US) — Related News

### [Small-cap value picks emerge despite rising yield pressures](https://longbridge.com/en/news/286854312.md)
*2026-05-19T04:43:18.000Z*
> A new shortlist highlights the top 10 small-cap stocks with low forward P/E and strong profitability, including Ironwood

### [Ironwood Pharma | 10-Q: FY2026 Q1 Revenue Beats Estimate at USD 106.51 M](https://longbridge.com/en/news/285609266.md)
*2026-05-07T20:14:02.000Z*
### [](https://longbridge.com/en/news/285572181.md)
*2026-05-07T14:33:18.000Z*
> The Nasdaq Biotechnology Index fell more than 1.9%. Among its constituents, Entrada Therapeutics dropped 55.80%, Phibro 

### [Ironwood Pharma | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 106.51 M](https://longbridge.com/en/news/285537526.md)
*2026-05-07T11:13:43.000Z*
### [Ironwood Pharmaceuticals Reports Strong First Quarter 2026 Results With 97% Year-Over-Year LINZESS U.S. Net Sales Growth; Maintains Full-Year 2026 Financial Guidance | IRWD Stock News](https://longbridge.com/en/news/285539580.md)
*2026-05-07T03:05:00.000Z*
> Ironwood Pharmaceuticals reported strong Q1 2026 results, with U.S. net sales of LINZESS reaching $273 million, a 97% in

### [Ironwood Pharmaceuticals Q1 2026 earnings preview](https://longbridge.com/en/news/285408430.md)
*2026-05-06T16:03:18.000Z*
> Ironwood Pharmaceuticals (IRWD) will announce its Q1 earnings on May 7th, with a consensus EPS estimate of $0.24 and rev